January saw three apartment loans transferred to special servicing, revealing distinct challenges in Colorado and Houston markets despite strong national trends.
As growth investing maintains its momentum, fueled by economic expansion and AI investment, we analyze three standout ETFs that offer investors diversified, cost-effective exposure to this high-performing segment.
Netflix's bold, all-cash offer to acquire Warner Bros. Discovery for an estimated $72-83 billion is testing investor confidence and regulatory boundaries. The proposed mega-deal, which would dramatically reshape the streaming landscape, faces intense scrutiny over antitrust concerns and the strain it could place on Netflix's historically disciplined balance sheet.
Barclays PLC announces a series of senior leadership appointments across its securitized products, payments, and European operations, signaling strategic focus areas as it prepares to relocate its EU hub to Paris.
Cotton futures trimmed early losses by midday Thursday, recovering slightly despite broader market pressure. The partial rebound followed a surprise announcement from former President Donald Trump regarding a new trade agreement with India, a key cotton importer.
The Trump administration is launching a strategic reserve for rare earths and critical minerals, echoing the 1970s response to the oil crisis, as global competition for tech supply chains intensifies.
The Hennepin County Medical Examiner has officially classified the January shooting death of ICU nurse Alex Pretti as a homicide, a finding that intensifies legal and public pressure on the federal agents involved amid ongoing protests and disputed official narratives.
A sharp post-holiday inventory drawdown is reshaping freight dynamics, with falling ocean container rates foreshadowing tighter truck capacity, higher rejection rates, and rising costs for shippers in the months ahead.
As artificial intelligence reshapes finance, we examine whether XRP's underlying technology is built to capitalize on the trend of 'agentic AI' handling transactions, or if its potential benefits remain speculative.
Expedia Group stock rose sharply after announcing an expanded, exclusive partnership with Affirm, making the fintech firm the sole 'Buy Now, Pay Later' provider across its major U.S. travel platforms.
Abbott Laboratories moves to acquire cancer-testing leader Exact Sciences in a landmark deal, signaling a strategic shift toward high-growth diagnostics while simultaneously restructuring its challenged Nutrition business.
Fifth Third Bancorp has finalized its $12.3 billion acquisition of Comerica Bank, with customer system conversions and branch rebranding scheduled to begin after Labor Day. The deal reshapes Michigan's banking landscape and creates the nation's ninth-largest bank.
As inflation persists, Baby Boomers are leveraging decades of financial experience to cut costs strategically. We examine the key spending categories they avoid and the generational mindset behind their money choices.
CNBC's Jim Cramer lauds Salesforce's operational strength, yet the stock, alongside peer ServiceNow, faces persistent 'multiple compression' as Wall Street reevaluates growth expectations for mature software leaders.
CNBC's Jim Cramer expressed reservations about aviation services provider AAR Corp., highlighting its 15% gross yield as a potential red flag for investors during a recent market analysis segment.
CNBC's Jim Cramer spotlighted Royal Caribbean Cruises Ltd. (RCL) this week, praising its ambitious full-year 2026 forecast as the cruise line capitalizes on robust post-pandemic demand and operational efficiencies.
CNBC's Jim Cramer positions Alphabet as the potential 'only winner in AI,' suggesting its upcoming earnings may show it generating more revenue from AI than rival Meta Platforms.
CNBC's Jim Cramer tempered enthusiasm for Novo Nordisk stock, suggesting investors hold rather than buy after its massive gains driven by blockbuster weight-loss drugs.
The Priestly Society of St. Pius X (SSPX) announced plans to consecrate new bishops in July without Vatican approval, escalating a decades-long doctrinal standoff and prompting concerns of a permanent rupture within the Catholic Church.
AbbVie's stock presents a complex picture for investors, with recent mixed performance contrasting sharply with its robust multi-year returns. As shares trade below consensus targets, the market weighs near-term headwinds against the pharmaceutical giant's proven track record and pipeline potential.
